Stock Events

Argent Biopharma 

$0.28
14
-$0-1.27% Today

Statistics

Day High
0.29
Day Low
0.27
52W High
9.5
52W Low
0.23
Volume
900
Avg. Volume
83
Mkt Cap
12.68M
P/E Ratio
0
Dividend Yield
-
Dividend
-

Upcoming

Earnings

26FebExpected
Q2 2022
Q3 2022
Q4 2022
Q1 2023
Q2 2023
Q3 2023
Q4 2023
0
0.33
0.67
1
Expected EPS
N/A
Actual EPS
N/A

People Also Follow

This list is based on the watchlists of people on Stock Events who follow MGCLF. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

About

Precious Metals
Pharmaceuticals: Other
Health Technology
Process Industries
Agricultural Commodities/Milling
MGC Pharmaceuticals Limited, a bio-pharma company, develops and supplies phytomedicines in worldwide. The company produces and supplies medicinal cannabis products; and non-cannabis phytomedicines. Its principal product candidates include CimetrA, which is in phase III clinical trial for the symptomatic treatment of early COVID-19; CannEpil, a phase IIb cannabis-based therapy for drug-resistant Epilepsy; and CogniCann that is in phase II clinical trial for the symptomatic relief of Dementia. The company also provides ArtemiC range of products and cannabinoid products, as well as non-pharma products. In addition, it offers consulting services, including clinical research services. The company was formerly known as Erin Resources Limited and changed its name to MGC Pharmaceuticals Limited in December 2015. MGC Pharmaceuticals Limited was founded in 2014 and is based in West Perth, Australia.
Show more...
CEO
Roby Zomer
Country
AU
ISIN
AU000000MXC6
WKN
000A2ACB6

Listings